Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction - Wikidata - wikimedia - TriplyDB

Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction

Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction

http://www.wikidata.org/entity/Q34751938

about

Phosphorus and the kidney: What is known and what is needed Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease Differential scaling of glomerular filtration rate and ingested metabolic burden: implications for gender differences in chronic kidney disease outcomes Phosphate metabolism modulation in chronic kidney disease: when, how and to what extent?VS-501: A NOVEL, NON-ABSORBED, CALCIUM- AND ALUMINUM-FREE, HIGHLY EFFECTIVE PHOSPHATE BINDER DERIVED FROM NATURAL PLANT POLYMER Mineral metabolism and outcomes in chronic kidney disease stage 2-4 patients.Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients.Re-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels--a four-years prospective cohort study in Taiwan Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010 Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment.Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease Joint Effect of Hypertension and Elevated Serum Phosphorus on the Risk of Mortality in National Health and Nutrition Examination Survey-III Mineral metabolites and CKD progression in African Americans Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder.The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know.Phosphate: an old bone molecule but new cardiovascular risk factor.Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate.Dietary phosphorus and kidney disease.Is there a need for new phosphate binders to treat phosphate imbalance associated with chronic kidney disease?Effects and safety of iron-based phosphate binders in dialysis patients: a systematic review and meta-analysis.Novel iron-containing phosphate binders for treatment of hyperphosphatemia.Pro: Should phosphate binders be used in chronic kidney disease stage 3-4?Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.Serum phosphate as an additional marker for initiating hemodialysis in patients with advanced chronic kidney disease.Associations between serum calcium, phosphorus and mortality among patients with coronary heart disease.Serum Phosphate Is Associated With Fracture Risk: The Rotterdam Study and MrOS.Excess mortality attributable to chronic kidney disease. Results from the PIRP project.Gender-related differences in long-term outcome among high-risk patients with myocardial infarction treated invasively Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients.Interaction of Serum Phosphate with Age as Predictors of Cardiovascular Risk Scores in Stable Renal Transplant Recipients.Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway.Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.Interaction between phosphorus and parathyroid hormone in non-dialysis CKD patients under nephrology care.Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification.Lower serum calcium is independently associated with CKD progression.Association between Dietary Mineral Intake and Chronic Kidney Disease: The Health Examinees (HEXA) Study.Treatment of hyperphosphatemia based on specific interactions between phosphorus and Zr(iv) active centers of nano-MOFs

P2860

Q26992251-5D63D8F9-59E4-4FD0-AFD6-FCA68FD1BB1F Q30852321-922934C2-BC88-446B-A00B-EE3821BB6C00 Q33749281-140C6872-F01F-4316-94E3-F598448D7161 Q33877167-D291354F-1E90-4492-B925-7AD749A75A02 Q34120727-2AE991A0-C956-4287-A722-8A19AD926DCF Q34550213-8E1D4564-A04F-4346-8E81-6B488A62B054 Q34629938-BD22A1E3-53DA-4477-B166-7C894D43B5FA Q34680658-D1EE5DBC-5666-4001-9E7D-8BE979BDFB94 Q34960805-EE0DC292-D5FB-4D2D-8B96-EB0BCA026DE5 Q35592504-447A9E3C-4DF6-4E53-A53C-66D3F3DA5795 Q35857872-32594CD2-698B-455E-8D7E-2ECF28D8BCA3 Q35898342-9B665B57-4DF1-4FDE-AAE1-E343501EAF81 Q36141334-6B362BA5-A5A4-4E95-B690-D35B873935AE Q36509327-93A92BA4-9EB3-4970-94D9-6E450CF190F6 Q37034750-937BB33E-570C-48CD-A569-D326EDF338BF Q37296494-BAAD4A4C-CA12-4106-8A95-F30A3B2260FD Q37492019-01A2D85A-19AD-47A8-AB95-DFD84D2B2522 Q37673143-75BFBCB9-8A52-49A1-A17F-95BF78307354 Q38049170-B98597EB-3FA1-4A01-89FE-EDAE4AB5C1D8 Q38123246-4BABFF40-5E16-44B0-9277-61265E95D841 Q38223280-8A73224F-7B6D-4CEC-85EA-4C18E76820C0 Q38263310-D4D0A59C-D1B8-41BF-89DA-70016AFF4909 Q38570622-05D0A590-374A-4FDF-9B2E-8983F8306AD6 Q38673170-A4F85655-F5C2-4F68-B401-20C345EECC59 Q38782222-1F9641C6-E58A-4207-BD27-1FD9FB5C7D4C Q39237776-0A0ACC3B-2923-42E8-BCA1-77CFF0DB06CB Q39889939-B18D96B8-E73F-46C2-9912-31E39E64AD7A Q40082986-F258AFC0-07FB-4C4A-8C63-B65E4E0B0CDA Q40344912-B176F062-A030-407C-8E8B-0A290383C3D4 Q40396356-166881DE-E4DB-43BE-BD22-B6E6591D907A Q41270498-79151CBF-E662-4F64-AD72-3E4A75660457 Q44204313-027191F9-09DF-42AA-AB21-BFDB96BC48CC Q50609788-F742ECE5-0047-4CE5-9CC0-DD5C736BC27A Q52673652-46BF12CA-9311-4B99-85D8-00EF21DDD52C Q53501050-EB77C4D9-9A61-4AB0-8F79-03DB9D41039B Q54306096-B6088258-0953-463D-BE8E-0B178089C425 Q55098165-7733F7DA-5ECC-499F-93E1-72D2696DC5FB Q55162820-9BDB69D5-39CE-4BF8-915F-947CDC699155 Q55688092-BB25666D-68E2-4FB7-96EC-9EE7EBA047EE Q57470029-13330EB5-9656-4410-BD80-4F8BB3EAEAAD

P2860

Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction

http://www.wikidata.org/entity/Q34751938

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@ast

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@en

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@nl

type

label

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@ast

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@en

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@nl

prefLabel

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@ast

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@en

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@nl

P1433

Q34751938-6B747C91-B0CE-4AEC-8FE5-93D67A7537F1

P1476

Q34751938-6F754AF1-EFEE-4F75-9608-D00637971A96

P2093

Q34751938-07F9347F-A410-43B8-B480-0172A7950E31

Q34751938-2371B840-FB3D-47FD-B663-3A8EFEE2A072

Q34751938-59CD3B71-91FF-4209-B366-9DA01635DE0D

Q34751938-5AFDC990-FE52-42D2-830D-35EB8C83DD89

Q34751938-748EBED1-FC28-4A7C-9D4E-16080CBD8639

Q34751938-A43DD0B4-1CF8-4C81-ABE6-03D73848A3CF

P2860

Q34751938-0A670831-BF06-4C2F-9058-12841112181E

Q34751938-0DCE8FCB-18B5-4351-8B44-1BA8652EB38F

Q34751938-1A936050-1471-445E-B2FD-358C8693464A

Q34751938-1B24A650-7655-4070-A485-E388A9A23A53

Q34751938-1BE707B6-D1E1-492C-9E1C-DCB78FAAF8DA

Q34751938-2661E17B-0002-451D-8528-04A7A22F2A4F

Q34751938-2F02F77E-B3F8-44F3-A5F1-B4EA637C70D8

Q34751938-46254A54-9263-4C4C-B7D8-492A7059C08B

Q34751938-4AA6C048-C4F1-4C3F-A3BD-DB1BB8315EA1

Q34751938-54E11790-05C8-4912-ACF7-EA6C9B7A94FE

P304

Q34751938-68BA90BD-9ED8-40F4-9245-1A183E751680

P31

Q34751938-4F3B6B9C-C1DA-4276-8D6F-6777F35A5D2D

P356

Q34751938-CB04D80C-6974-4A9F-888B-EA426E9DA6C9

P433

Q34751938-684CCFC3-D04B-4704-8479-09F1A04764CF

P478

Q34751938-BDB156E3-33C7-40F1-AB8A-43C8509E737F

P50

Q34751938-BACD61EE-FB34-4500-A950-3FEABA9E64DB

P577

Q34751938-9F386F9F-7FF1-4CFC-8A91-69E174B0EF00

P5875

Q34751938-C5F2B797-7516-4852-BDD5-726EEBDF48D8

P698

Q34751938-F76D1061-61B9-499B-95A9-BB15B069C2E3

P932

Q34751938-E681A9CE-FF42-42D3-8467-7364C258F21C

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Chronic kidney disease progres ...... to-moderate kidney dysfunction

@en

P2093

Antonio Bellasi

http://www.w3.org/2001/XMLSchema#string

Antonio Santoro

http://www.w3.org/2001/XMLSchema#string

Giulio Malmusi

http://www.w3.org/2001/XMLSchema#string

Leopoldo Baldrati

http://www.w3.org/2001/XMLSchema#string

Marcora Mandreoli

http://www.w3.org/2001/XMLSchema#string

Matteo Corradini

http://www.w3.org/2001/XMLSchema#string

P2860

Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients.

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

"Phosphatonins" and the regulation of phosphorus homeostasis.

Endocrine functions of bone in mineral metabolism regulation.

Serum phosphorus levels associate with coronary atherosclerosis in young adults.

Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality.

Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease.

Indirect regulation of PTH by estrogens may require FGF23.

P304

883-891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.07810910

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Pierpaolo Di Nicolò

P577

2011-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50363862

http://www.w3.org/2001/XMLSchema#string

P698

21393493

http://www.w3.org/2001/XMLSchema#string

P932

3069383

http://www.w3.org/2001/XMLSchema#string